Predictions
Stabilus SE
Start price
Target price
Perf. (%)
€56.85
28.01.22
28.01.22
€62.00
28.01.23
28.01.23
13.28%
29.01.23
29.01.23
Could be worthwhile Investment >10% per year
Rheinmetall AG
Start price
Target price
Perf. (%)
€93.66
27.01.22
27.01.22
€104.00
27.07.22
27.07.22
138.95%
29.06.22
29.06.22
Top 10 in its market
Stable Large shareholder and/or long term investor
Differentiated customer and product portfolio
Revenue growth >5% per year expected
Quoin Pharmaceuticals Ltd. ADR
Start price
Target price
Perf. (%)
€13.88
25.01.22
25.01.22
€25.00
25.01.23
25.01.23
9.01%
05.02.22
05.02.22
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
BioNTech SE ADR
Start price
Target price
Perf. (%)
€134.45
25.01.22
25.01.22
€200.00
25.01.23
25.01.23
16.36%
05.02.22
05.02.22
Rising EBIT margin expected
Good rating
High Investments for future growth
Valuable balance sheet
Evonik Industries AG
Start price
Target price
Perf. (%)
€28.58
24.01.22
24.01.22
-
24.01.26
24.01.26
-40.08%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Zoom Video Communications Inc
Start price
Target price
Perf. (%)
€124.20
24.01.22
24.01.22
€112.00
24.01.23
24.01.23
3.83%
30.01.22
30.01.22
Top 10 in its market
Future proof or reliable business model
negative Cash Flow expected
Significant cyclical dependencies
Aecom Tech.c.(del.)
Start price
Target price
Perf. (%)
€62.50
24.01.22
24.01.22
€57.00
24.01.23
24.01.23
12.00%
16.03.22
16.03.22
Higher EBIT margin than peer group
Fair valuation
ROE higher than 10% per year
Good rating
Boston Beer Company Inc.
Start price
Target price
Perf. (%)
€390.00
24.01.22
24.01.22
€290.00
24.01.23
24.01.23
-6.82%
26.11.22
26.11.22
Good rating
Standard Investments for future growth
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Teladoc Health Inc
Start price
Target price
Perf. (%)
€60.46
24.01.22
24.01.22
€52.00
24.01.23
24.01.23
5.86%
30.01.22
30.01.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Pan American Silver Corp.
Start price
Target price
Perf. (%)
€20.94
24.01.22
24.01.22
-
24.01.23
24.01.23
-8.88%
05.02.22
05.02.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Cronos Group Inc.
Start price
Target price
Perf. (%)
€3.03
24.01.22
24.01.22
-
24.01.23
24.01.23
18.13%
28.03.22
28.03.22
Could be very worthwhile Investment >20% year
BioNTech SE ADR
Start price
Target price
Perf. (%)
€131.05
23.01.22
23.01.22
-
23.01.23
23.01.23
19.38%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Moderna Inc.
Start price
Target price
Perf. (%)
€137.00
23.01.22
23.01.22
-
23.01.23
23.01.23
4.37%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Cronos Group Inc.
Start price
Target price
Perf. (%)
€3.03
23.01.22
23.01.22
-
23.01.23
23.01.23
6.03%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€6.43
23.01.22
23.01.22
-
23.01.23
23.01.23
7.21%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Tilray Inc
Start price
Target price
Perf. (%)
€5.18
23.01.22
23.01.22
-
23.01.23
23.01.23
2.35%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Gamesa Corp.
Start price
Target price
Perf. (%)
€16.75
23.01.22
23.01.22
-
23.01.23
23.01.23
2.57%
09.02.22
09.02.22
Could be worthwhile Investment >10% per year
Nordex SE ADR
Start price
Target price
Perf. (%)
€6.00
23.01.22
23.01.22
-
23.01.23
23.01.23
5.83%
04.02.22
04.02.22
Could be worthwhile Investment >10% per year
High valuation
BioNTech SE ADR
Start price
Target price
Perf. (%)
€131.05
22.01.22
22.01.22
€150.00
22.01.23
22.01.23
19.38%
06.02.22
06.02.22
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Standard Investments for future growth
Capable Management
Moderna Inc.
Start price
Target price
Perf. (%)
€137.00
22.01.22
22.01.22
€165.00
22.01.23
22.01.23
4.37%
06.02.22
06.02.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business